10th 3D Tissue Models Summit 2025

May 6, 2025 - May 8, 2025

Following the FDA's introduction of the Modernization Act 3.0 and the latest guidance on new approach methods (NAMs), GSK developing a new lung organoid model to empower pulmonary fibrosis research, and Merck acquiring HUB Organoids to enable more effective drug development and reduce reliance on animal testing, it's an exciting time for pharma and biotech to leverage complex in vitro models in drug discovery and development.

Despite this growth, challenges persist in standardizing protocols for model validation, safeguarding model reproducibility while ensuring scalability, and understanding what data regulators will accept.

Date and Time: Tuesday, 06 May 2025 at 09:00 to Thursday, 08 May 2025 at 15:15

Latest from Events